Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
LP
Linker Pharmaceuticals ApS
aktivCVR 44308622AnpartsselskabAmaliegade 13, 3, 1256 København KFremstilling af farmaceutiske præparater
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 06 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Data quality concern—
Data quality concern
Operating profit
Data quality concern—
Data quality concern
Net result
DKK -268.4k
Latest period
Source details
Source: dk-regnskabsdata-live-44308622-1793937851751
Document: dk-regnskabsdata-44308622-AZ8nVYIx3IJM1qH2_PBq-1
XBRL: fsa:ProfitLoss
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: D0
Unit: U-iso4217-DKK
Equity
DKK 57.2k
Equity ratio: 53.3%
Source details
Source: dk-regnskabsdata-live-44308622-1793937851751
Document: dk-regnskabsdata-44308622-AZ8nVYIx3IJM1qH2_PBq-1
XBRL: fsa:Equity
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: I0
Unit: U-iso4217-DKK
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2024 | — | DKK -11.3k |
| 2025 | — | DKK -268.4k |